Literature DB >> 14722629

Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.

Duncan J Macrae1, David Field, Jean-Christophe Mercier, Jens Møller, Tom Stiris, Paolo Biban, Paul Cornick, Allan Goldman, Sylvia Göthberg, Lars E Gustafsson, Jürg Hammer, Per-Arne Lönnqvist, Manuel Sanchez-Luna, Gunnar Sedin, Nim Subhedar.   

Abstract

Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14722629     DOI： 10.1007/s00134-003-2122-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  68 in total

1.  Inhaled nitric oxide does not influence bleeding time or platelet function in healthy volunteers.

Authors:  J Albert; M Norman; N H Wallén; C Frostell; P Hjemdahl
Journal:  Eur J Clin Invest       Date:  1999-11       Impact factor: 4.686

2.  Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn.

Authors:  H Aly; R Sahni; J T Wung
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

3.  Recovery from withdrawal of inhaled nitric oxide and kinetics of nitric oxide-induced inhibition of nitric oxide synthase activity in vitro.

Authors:  J Dötsch; S Demirakça; K Zepf; J Hänze; S Parida; W Rascher
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

4.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

5.  Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group.

Authors:  D Davidson; E S Barefield; J Kattwinkel; G Dudell; M Damask; R Straube; J Rhines; C T Chang
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

6.  Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. The Franco-Belgium Collaborative NO Trial Group.

Authors: 
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

7.  Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances.

Authors:  U Schedin; C G Frostell; L E Gustafsson
Journal:  Br J Anaesth       Date:  1999-02       Impact factor: 9.166

8.  Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure.

Authors:  E L Dobyns; D N Cornfield; N G Anas; J D Fortenberry; R C Tasker; A Lynch; P Liu; P L Eells; J Griebel; M Baier; J P Kinsella; S H Abman
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

9.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

10.  Guidelines for the safe administration of inhaled nitric oxide.

Authors:  O I Miller; D S Celermajer; J E Deanfield; D J Macrae
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747
View more
  23 in total

Review 1.  Role of nitric oxide in hepatic ischemia-reperfusion injury.

Authors:  Arunotai Siriussawakul; Ahmed Zaky; John D Lang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Inhaled nitric oxide therapy in adults--opinions and evidence.

Authors:  Luca M Bigatello; H Thomas Stelfox; Dean Hess
Journal:  Intensive Care Med       Date:  2005-06-23       Impact factor: 17.440

3.  Inhaled nitric oxide therapy in adults: European expert recommendations.

Authors:  Peter Germann; Antonio Braschi; Giorgio Della Rocca; Anh Tuan Dinh-Xuan; Konrad Falke; Claes Frostell; Lars E Gustafsson; Philippe Hervé; Philippe Jolliet; Udo Kaisers; Hector Litvan; Duncan J Macrae; Marco Maggiorini; Nandor Marczin; Bernd Mueller; Didier Payen; Marco Ranucci; Dietmar Schranz; Rainer Zimmermann; Roman Ullrich
Journal:  Intensive Care Med       Date:  2005-06-23       Impact factor: 17.440

Review 4.  Inhaled nitric oxide and related therapies.

Authors:  Frederick E Barr; Duncan Macrae
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

5.  Respiratory support practices in infants born at term in the United Kingdom.

Authors:  Olie Chowdhury; Catherine J Wedderburn; Silke Lee; Simon Hannam; Anne Greenough
Journal:  Eur J Pediatr       Date:  2012-07-22       Impact factor: 3.183

6.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

7.  Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery.

Authors:  Tsvetomir Loukanov; Dietrich Bucsenez; Wolfgang Springer; Christian Sebening; Helmut Rauch; Eva Roesch; Matthias Karck; Matthias Gorenflo
Journal:  Clin Res Cardiol       Date:  2011-02-13       Impact factor: 5.460

8.  A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome.

Authors:  Robert Lindwall; Mats Blennow; Mats Svensson; Baldvin Jonsson; Eva Berggren-Boström; Martino Flanby; Per-Arne Lönnqvist; Claes Frostell; Mikael Norman
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

9.  Prolonged exposure to inhaled nitric oxide does not affect haemostasis in piglets.

Authors:  Johanna Albert; Piotr Harbut; Stanisław Zieliński; Stanisław Ryniak; Caroline Gillis-Haegerstrand; Robert Lindwall; Leszek Solski; Jon O Lundberg; Jan Svensson; Waldemar Goździk
Journal:  Intensive Care Med       Date:  2007-05-12       Impact factor: 17.440

10.  Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol.

Authors:  Erika E Vorhies; Regine L Caruthers; Howard Rosenberg; Sunkyung Yu; Robert J Gajarski
Journal:  Pediatr Cardiol       Date:  2014-05-29       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.